{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:44:53Z","timestamp":1792007093293,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jsbmb.2017.07.008","type":"journal-article","created":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T01:32:40Z","timestamp":1500082360000},"page":"250-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Recent developments for introducing a hexafluoroisopropanol unit into the Vitamin D side chain"],"prefix":"10.1016","volume":"177","author":[{"given":"Fumihiro","family":"Kawagoe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motonari","family":"Uesugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kittaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2017.07.008_bib0005","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/14756360701425014","article-title":"The role of fluorine in medicinal chemistry","volume":"22","author":"Shah","year":"2007","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0010","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1021\/ja01478a001","article-title":"Electronegativity","volume":"83","author":"Iczkowski","year":"1961","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0015","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1021\/jm981133m","article-title":"Fluorination of 3-[3-(piperidin-1-yl)propyl]indoles and 3-[3-(piperazin-1-yl)propyl]indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles","volume":"42","author":"van Niel","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0020","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1248\/bpb.22.590","article-title":"Synthesis and characterization of lipophilic 1-[18F]fluoroalkyl-2-nitroimidazoles for imaging hypoxia","volume":"22","author":"Yamamoto","year":"1999","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0025","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1021\/acs.jmedchem.5b00258","article-title":"Applications of fluorine in medicinal chemistry","volume":"58","author":"Gillis","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0030","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1021\/cr4002879","article-title":"Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001\u20132011)","volume":"114","author":"Wang","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0035","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1126\/science.1131943","article-title":"Fluorine in pharmaceutical; Looking beyond intuition","volume":"317","author":"M\u00fcller","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0040","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0039-128X(98)00055-5","article-title":"Distribution and metabolism of F6-1,25(OH)2 vitamin D3 and 1,25(OH)2 vitamin D3 in the bones of rats dosed with tritium-labeled compounds","volume":"63","author":"Komuro","year":"1998","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0045","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0006-2952(03)00190-4","article-title":"Metabolism of 26,26,26,27,27,27-F6-1\u03b1,25-dihydroxyvitamin D3 by CYP24: Species-based difference between humans and rats","volume":"65","author":"Sakaki","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0050","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/dmd.104.002303","article-title":"Metabolism of 26,26,26,27,27,27-F6-1\u03b1,23S,25-trihydroxyvitamin D3 by human UDP-glucuronosyltransferase 1A3*","volume":"33","author":"Kasai","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0169-6009(92)90798-I","article-title":"Effects on cultured neonatal mouse calvaria of 1\u03b1,25-dihydroxyvitamin D3, 26,26,26,27,27,27-hexafluoro-1\u03b1,25-dihydroxyvitamin D3 and 26,26,26,27,27,27-hexafluoro-1\u03b1,23S,25-trihydroxyvitamin D3","volume":"18","author":"Harada","year":"1992","journal-title":"Bone Miner."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0060","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/0006-2952(93)90207-D","article-title":"Effect of substituting fluorine for hydrogen at C-26 and C-27 on the side chain of 1,25-dihydroxyvitamin D3","volume":"45","author":"Inaba","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0065","first-page":"683","article-title":"Relationship between differentiation-inducing activity of hexafluorotrihydroxyvitamin D3 derivatives","volume":"24","author":"Unten","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0070","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1039\/c39800000459","article-title":"Synthesis of 26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D3","author":"Kobayashi","year":"1980","journal-title":"J. Chem. Soc. Chem. Comm."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0075","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1248\/cpb.30.4297","article-title":"Studies on organic fluorine compounds. XXXIX. Studies on steroids. LXXIX. Synthesis of 1\u03b1,\u200b25-\u200bdihydroxy-\u200b26,\u200b26,\u200b26,\u200b27,\u200b27,\u200b27-\u200bhexafluorovitamin D3","volume":"30","author":"Kobayashi","year":"1982","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0080","first-page":"2023","article-title":"Synthesis of 24,24-difluoro- and 24\u03be-fluoro-25-hydroxyvitamin D3","volume":"22","author":"Kobayashi","year":"1972","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0085","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1248\/cpb.43.1897","article-title":"Preparation and biological activity of 24-epi-26, 26, 26, 27, 27, 27-hexafluoro-1\u03b1, 25-dihydroxyvitamin D2","volume":"43","author":"Iseki","year":"1995","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0090","doi-asserted-by":"crossref","first-page":"8147","DOI":"10.1016\/S0040-4039(00)61475-2","article-title":"Reversal of stereoselectivity in the Evans aldol reaction of \u03b1,\u03b1-difluoro and \u03b1,\u03b1,\u03b1-trifluoro carbonyl compounds","volume":"34","author":"Iseki","year":"1993","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0095","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1248\/cpb.40.1647","article-title":"Preparation of (22S)- and (22R)-24-homo-26,26,26,27,27,27-hexafluoro-1,22,25-trihydroxy-24-yne-vitamin D3","volume":"40","author":"Ohira","year":"1992","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0100","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0960-894X(02)00221-4","article-title":"Vitamin D3: synthesis of seco-C-9,11,21-trisnor-17-methyl-1\u03b1,25-dihydroxyvitamin D3 analogues","volume":"12","author":"Wu","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0105","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/S0960-894X(02)00222-6","article-title":"Vitamin D3: synthesis of seco-C-9,11-bisnor-17-methyl-1\u03b1,25-dihydroxyvitamin D3 analogues","volume":"12","author":"Wu","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0110","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0968-0896(00)00106-1","article-title":"Synthesis and biological evaluations of C-23-modified 26,26,26,27,27,27-F6-vitamin D3 analogues","volume":"8","author":"Ikeda","year":"2000","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0115","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1021\/acs.jmedchem.5b02021","article-title":"Synthesis structural elucidation, and biological evaluation of NSC12, an orally available fibroblast growth factor (FGF) ligand trap for the treatment of FGF-dependent lung tumors","volume":"59","author":"Castelli","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0120","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/(SICI)1521-3773(19980403)37:6<820::AID-ANIE820>3.0.CO;2-M","article-title":"Direct preparation of trifluoromethyl ketones from carboxylic esters: trifluoromethylation with (trifluoromethyl)trimethylsilane","volume":"37","author":"Wiedemann","year":"1998","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0125","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1016\/0040-4039(91)85094-L","article-title":"A short, flexible route to vitamin D metabolites and their side chain analogues","volume":"32","author":"Mascarefias","year":"1991","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0130","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1021\/jo00157a004","article-title":"Studies on a convergent route to side-chain analogues of vitamin D: 25-Hydroxy-23-oxavitamin D3","volume":"48","author":"Toh","year":"1983","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0135","unstructured":"1H and 13C NMR spectra for compound 9: 1H NMR (600\u2009MHz, CDCl3) \u03b4: 0.54 (s, 3H), 0.91 (s, 1H), 0.94 (d, J\u2009=\u20097.2\u2009Hz, 3H), 1.03\u20131.11 (m, 1H), 1. 21\u20131.70 (m, 15H), 1.79\u20132.00 (m, 5H), 2.15\u20132.19 (m, 1H), 2.28 (dd, J\u2009=\u20097.2, 12.6\u2009Hz, 1H), 2.36\u20132.41 (m, 1H), 2.57 (dd, J\u2009=\u20093.6, 13.8\u2009Hz, 1H), 2.80\u20132.83 (m, 1H), 3.92\u20133.98 (sept, J\u2009=\u20093.6\u2009Hz, 1H), 4.81 (d, J\u2009=\u20091.8\u2009Hz, 1H), 5.04 (d, J\u2009=\u20091.8\u2009Hz, 1H), 6.03 (d, J\u2009=\u200910.8\u2009Hz, 1H), 6.23 (d, J\u2009=\u200910.8\u2009Hz, 1H); 13C NMR (150\u2009MHz, CDCl3) \u03b4: 12.1, 18.7, 18.8, 22.4, 23.7, 27.8, 29.1, 30.5, 31.0, 32.1, 35.2, 36.1, 36.3, 40.7, 46.0, 56.4, 56.5, 69.4, 76.4 (sept, J\u2009=\u200928.8\u2009Hz), 112.6, 117.7, 122.6, 123.4 (q, J\u2009=\u2009272.9\u2009Hz), 135.2, 142.2, 145.2."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0140","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1021\/jo900524u","article-title":"Synthesis of 25-hydroxyvitamin D3 and\u0303 26, 26, 26, 27, 27, 27-hexadeutero-25-hydroxyvitamin D3 on solid support","volume":"74","author":"Nicoletti","year":"2009","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.jsbmb.2017.07.008_bib0145","unstructured":"1H and 13C NMR spectra for compound 33: 1H NMR (600\u2009MHz, CDCl3) \u03b4: 0.91 (d, J\u2009=\u20096.6\u2009Hz, 3H), 0.92 (s, 3H), 1.01\u20131.18 (m, 2H), 1.15 (td, J\u2009=\u20094.2, 13.2\u2009Hz, 1H), 1.24\u20131.62 (m, 11H), 1.76\u20131.87 (m, 4H), 1. 88\u20131.94 (m, 1H), 1.99 (dt, J\u2009=\u20092.4, 13.2\u2009Hz, 1H), 3.48 (brs, 1H), 4.08 (d, J\u2009=\u20093.0\u2009Hz, 1H); 13C NMR (150\u2009MHz, CDCl3) \u03b4: 13.6, 17.4, 18.5, 18.5, 22.5, 27.2, 31.0, 33.5, 35.2, 36.1, 40.4, 41.9, 52.6, 56.6, 69.6, 76.3 (sept, J\u2009=\u200928.7\u2009Hz), 123.3 (q, J\u2009=\u2009284.3\u2009Hz)."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076017301735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076017301735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:59:52Z","timestamp":1760745592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076017301735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":29,"alternative-id":["S0960076017301735"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2017.07.008","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent developments for introducing a hexafluoroisopropanol unit into the Vitamin D side chain","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2017.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}